5-Bromo-2-fluoro-3-nitropyridine

Catalog No.: 
ACXZIY278
CAS No.: 
886372-98-1
Molecular Formula: 
C5H2BrFN2O2
Molecular Weight: 
220.99
5-Bromo-2-fluoro-3-nitropyridine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
25g97%$56.00InquiryInquiry
100g97%$219.00InquiryInquiry
500g97%$874.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5-Bromo-2-fluoro-3-nitropyridine
IUPAC Name5-bromo-2-fluoro-3-nitropyridine
MDL No.MFCD07375020
Molecular FormulaC5H2BrFN2O2
Molecular Weight220.99
SMILESO=[N+](C1=CC(Br)=CN=C1F)[O-]
InChI KeySGDKTJPVCKQTHK-UHFFFAOYSA-N
Synonym5-BROMO-2-FLUORO-3-NITROPYRIDINE | 886372-98-1 | 2-fluoro-3-nitro-5-bromopyridine | MFCD07375020 | SELENIUMOXYCHLORIDE | SCHEMBL16095369 | AMY5212 | DTXSID20652060 | AC2040 | BBL103364 | STL557174 | AKOS005256447 | AB40965 | CS-W005566 | 5-bromanyl-2-fluoranyl-3-nitro-pyridine | 2-FLU
CAS No.886372-98-1
PubChem CID29919389

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACXZIY278 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACXZIY278 route compound structure diagram
    ACXZIY278886372-98-1
  4. Then
  5. ACXZIY278 route product structure diagram
    ACXZIY278886372-98-1
Inquiry

2. ACXZIY278 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACXZIY278 route product structure diagram
    ACXZIY278886372-98-1
Inquiry

3. ACXZIY278 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACXZIY278 route product structure diagram
    ACXZIY278886372-98-1
Inquiry

Comments (0)